A Clinical Trial Evaluating the Safety and Clinical Activity of Radioiodide (131I-) as a Novel Targeted Therapy for Metastatic Breast Cancer That Overexpresses Functional Na/I Symporter

NCT02988648 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The study was withdrawn due to lack of enrollment.

Conditions

Breast Cancer

Interventions

RADIATION: Radioiodide (131I-)

Sponsor

Yale University